Dr. Amy Egan, MD, MPH

Dr. Amy Egan, MD, MPH

Work:

Principal, Amy G Egan Consulting LLC

Education:

Master of Public Health, Johns Hopkins Bloomberg School of Public Health

Dr. Amy Egan has over 15 years of experience in FDA Drug Safety and Regulatory Oversight. She earned her BS in Biology from Santa Clara University, her MD from Loyola University Stritch School of Medicine, and her MPH from Johns Hopkins Bloomberg School of Public Health. She completed her internship and residency in Internal Medicine at Evanston Northwestern Healthcare. Today, this expert is board-certified in Internal Medicine by the American Board of Internal Medicine. Formerly, this expert held roles as the Deputy Director of Dermatology and Dental Products and as the Deputy Safety Director for the Division of Metabolism and Endocrinology Products for the US Federal Drug Administration. She also served as an Internist and as the Officer of the Professional Staff at Evanston Northwestern Healthcare. Currently, she serves as the Principal at Amy G Egan Consulting LLC, where she specializes in FDA regulatory matters.

email icon

a*********@g*****.com

phone icon

(301) ***-****

location icon

Bonita Springs, Florida

At a Glance

Expert Witness Activity

lock icon

Plaintiff Cases

lock icon

Defense Cases

lock icon

Other Cases

lock icon

Expert Challenges

lock icon

Malpractice Cases

lock icon

Deposition Transcripts

lock icon

Personal Litigation

lock icon

Publications

lock icon

Media & News

435

Social Media Mentions

lock icon

Expert Institute operates independently and objectively as an expert witness data provider. Expert witness profiling focuses on individuals involved in publicly disclosed litigation. Expert Institute does not employ, endorse, or suggest an affiliation with any individuals for whom data is available.

Litigation Activities

Case Name

Role

Filed Date

Gilead Tenofovir Cases

Expert Witness

2019-09-04

green checkmark

Unlock Dr. Amy Egan, MD, MPH's full profile

See their litigation activity, risk and credibility history

Litigation Analytics

Retained By

Defense

Plaintiff

Activity over time

0

25

50

75

100

2000

0

2002

0

2004

0

2006

0

2008

0

2010

0

Area of Law

2001-2009

2001-2009

2001-2009

2001-2009

2001-2009

2001-2009

2001-2009

2001-2019

0

25

50

75

100

Activity by state

Map of USA

Case Outcome

0

25

50

75

100

Unlock Dr. Amy Egan, MD, MPH's full profile

See their litigation activity, risk and credibility history

Publications

Title

Type

Clinical Review of Safety and Efficacy: Division of Metabolism and Endocrinology Products - Rimonabant Briefing Document

Review

green checkmark

Unlock Dr. Amy Egan, MD, MPH's full profile

See their litigation activity, risk and credibility history

5 stars

Using Expert Radar, we uncovered a textbook chapter written by the opposing expert that contradicted his testimony, helping us secure a $44 million verdict—the largest single verdict for a single plaintiff in Kentucky's history.

Mark Alcott, Esq.

Harlin Parker

Media & News

435 records available

Title

Description

lyrglvTyyd - vykypdyh

Mar 11, 2024 -- JAMA Internal Medicine. 173: 534. doi:10.1001 ... Amy G. Egan, M.D., M.P.H., Eberhard Blind, M.D., Ph.D., Kristina Dunder, M.D., Pieter A.

Lipids and Cardiovascular Risk Management Perspective - Index

Medscape Internal Medicine, August 12, 2011. Simvastatin 80 mg: An FDA Expert Interview Medscape talked to the FDA's Amy Egan, MD, about drug safety ...

ALXN-1215 - New Drug Approvals

... Amy G. Egan, M.D., M.P.H., deputy director of the Office of Drug Evaluation III in the FDA's Center for Drug Evaluation and Research (CDER). "Strensiq's ...

green checkmark

Unlock Dr. Amy Egan, MD, MPH's full profile

See their litigation activity, risk and credibility history

Education

Institution

Degree Type

Johns Hopkins Bloomberg School of Public Health

Master of Public Health

Loyola University Chicago Stritch School of Medicine

Doctor of Medicine

Georgetown University School of Medicine

Other

Work History

Title

Employer

Principal

Amy G Egan Consulting LLC

Deputy Director - Office of Drug Evaluation III (“ODE III”)

United States Federal Drug Administration - Center for Drug Evaluation and Research (“CDER”)

Deputy Director of Safety - Division of Metabolism and Endocrinology Products (“DMEP”)

United States Federal Drug Administration - Center for Drug Evaluation and Research (“CDER”)

Get critical intel on Dr. Amy Egan, MD, MPH

lock icon

Contradictory statements in testimony

lock icon

Misrepresentations in CVs, online profiles / bios, LinkedIn

lock icon

Biases in expert witness experience

lock icon

Financial ties with organizations they represent